Healthcare Analysing Sepsis Management Part I: Diagnosis

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

INDUSTRY
Healthcare

RELEASE DATE
22-Jun-2020
REGION
North America
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D995-01-00-00-00
SKU
HC03306-NA-TR_24516
Yes
SHARE

Analysing Sepsis Management Part I: Diagnosis
Published on: 22-Jun-2020 | SKU: HC03306-NA-TR_24516

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Sepsis diagnosis

The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms. 

The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors.

The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis. 

A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out. 

Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches. 

Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.

1.1 Research Scope: Sepsis Diagnosis

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Technology Breakthrough Driving Sepsis Diagnosis

2.1 Research Scope: Current Status and Challenges of Sepsis Diagnosis

2.2 Types of Sepsis Diagnosis Tests

3.1 Fundamentals and Epidemiology of Sepsis

3.2 Unmet Needs in Sepsis Management

4.1 Outlook of Sepsis Diagnosis Clinical Trials

4.2 Industry Sponsored Sepsis-Diagnostic Test Clinical Trials

4.3 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in Europe

4.4 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in the Americas, Asia and Rest of the World

4.5 Scholarly Publications Including Patents for Sepsis

5.1 List of COMPANIES in Sepsis Diagnosis

5.2 The US Is The Biggest Hub For Sepsis Diagnosis

5.3 Procalcitonin-based Sepsis Diagnosis

5.4 Procalcitonin and Combination-based Sepsis Diagnosis Technologies

5.5 Sepsis Diagnosis Through Multiple Novel Immunoassays

5.6 Sequencing-based Detection of Sepsis Causing Pathogens

5.7 AI-Sequencing Platforms for Sepsis Causing Pathogen Detection

5.8 Machine Learning AND Host gene expression-based Platforms for sepsis diagnosis

5.9 Mass Spectroscopy-based Sepsis Diagnosis Platforms

5.10 Novel Platforms for Sepsis Diagnosis

5.11 Analyzers and Devices for Sepsis Diagnosis

5.12 Europe: PCR-based Sepsis Diagnosis Platforms

5.13 Americas: PCR-based Sepsis Diagnosis Platforms from big Companies

5.14 Americas: PCR-based Sepsis Diagnosis Platforms from mid-sized Companies

5.15 Americas: PCR-based Sepsis Diagnosis Platforms from small Companies

5.16 Asia: PCR-based Sepsis Diagnosis Platforms

5.17 Sepsis Diagnosis Tests under Development

5.18 Sepsis Diagnosis Companies with Revenue

6.1 Growth Opportunity 1: Selecting the Perfect Test for Specific Need

6.2 Growth Opportunity 2: Business Opportunities Beyond Diagnosis

7.1 Industry Interactions

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

06 Oct 2026   |   Global   |   Technology Research

Trends in Laboratory Automation, Global, 2021–2025

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...

05 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026

The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...

25 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...

23 Sep 2026   |   Global   |   Technology Research

Programmable Epigenome Editing for Disease Reversal

Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...

21 Sep 2026   |   Europe   |   Market Research

HLTH Europe 2026: Five Key Takeaways and Growth Opportunities

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms.  The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors. The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis.  A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out.  Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches.  Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.
More Information
Deliverable Type Technology Research
No Index No
Podcast No
Author Harshal Patil
Industries Healthcare
WIP Number D995-01-00-00-00
Is Prebook No

Analysing Sepsis Management Part I: Diagnosis

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03306-NA-TR_24516